In brief, SPARC could play an important role in ovarian cancer cell proliferation by controlling cell cycle progression, but how depletion of SPARC can lead to activation of the p53/p21 (Cip1/Waf1) signaling pathway needs further study. This evidence concerns the gene TP53 and ovarian carcinoma.